Autoplaque vs VitalRhythm
AI Verdict
Choose Autoplaque if…
Choose Autoplaque if your primary need is detailed, quantitative analysis of coronary plaques and luminal stenoses from CT angiography images. This tool is ideal for cardiologists and radiologists focused on precise heart attack risk prediction and guiding interventional treatment strategies based on anatomical plaque burden, offering a workstation-based solution for in-depth post-processing of imaging data.
View Autoplaque →Choose VitalRhythm if…
Choose VitalRhythm if you require continuous, remote monitoring for cardiac arrhythmia detection and analysis. This cloud-based AI software, integrated with the VitalPatch biosensor, is best suited for managing patients with suspected or known arrhythmias over extended periods, enabling timely intervention and supporting non-urgent clinical decision-making from a distance.
View VitalRhythm →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Autoplaque | VitalRhythm |
|---|---|---|
| Deployment | Workstation-based post-processing application, runs on Windows or Mac OS. | Cloud-based |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
VitalRhythmVitalRhythm (Tool B) offers higher inherent usability due to its cloud-based platform and the 'wear and forget' design of its VitalPatch biosensor, simplifying the patient experience and clinical workflow for continuous monitoring. Autoplaque (Tool A) is workstation-based, requiring a separate post-processing step and specific training, which can be less integrated into a real-time clinical environment.
Clinical Value
AutoplaqueBoth tools offer significant, FDA-cleared clinical value, but Autoplaque (Tool A) provides deep, quantitative analysis of coronary plaque for heart attack risk prediction, supported by extensive clinical validation demonstrating its predictive power for myocardial infarction. While VitalRhythm (Tool B) offers valuable continuous arrhythmia detection for remote patient management, Autoplaque's focus on advanced plaque characterization for high-stakes risk prediction from CTA data offers a deeper and more specific clinical insight in a critical area of cardiology.
Pricing & Value
TieNeither Autoplaque (Tool A) nor VitalRhythm (Tool B) discloses public pricing information, with both requiring direct contact for a quote. Without any public details on their respective costs or pricing models, it is impossible to conduct a meaningful comparison of their pricing or assess their value proposition.
Enterprise Readiness
VitalRhythmVitalRhythm (Tool B) explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA), which are crucial for enterprise adoption in healthcare, and its cloud-based deployment simplifies large-scale rollout. Autoplaque (Tool A), while usable in HIPAA-compliant studies, lacks explicit public statements on BAA and HIPAA compliance from its commercial licensee and is workstation-based, making it appear less enterprise-ready on paper.
Innovation
VitalRhythmWhile Autoplaque (Tool A) is innovative for its highly validated, AI-driven quantitative analysis of coronary plaque for heart attack risk prediction, VitalRhythm (Tool B) demonstrates greater innovation by integrating AI with a wearable biosensor for continuous, remote patient monitoring of a broad range of arrhythmias. This end-to-end solution for continuous, real-time, and remote monitoring represents a more transformative approach to cardiac care.
Support & Docs
VitalRhythmVitalRhythm (Tool B) offers more comprehensive and readily accessible support resources, including dedicated contact channels for various needs and patient-facing instructional videos and documents. Autoplaque (Tool A) lacks publicly available details regarding its support structure, documentation, or training programs, making it difficult to assess its offerings in this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Autoplaque | VitalRhythm |
|---|---|---|
| Name | Autoplaque | VitalRhythm |
| Company | Cedars-Sinai Medical Center: AIM | VitalConnect |
| Description | Autoplaque, developed by Cedars-Sinai AIM, is an FDA-cleared AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance. | VitalRhythm by VitalConnect is an AI-powered cloud-based software for continuous cardiac arrhythmia detection and analysis, integrating with the VitalPatch biosensor for remote patient monitoring. |
| Key Features | AI-powered quantitative analysis of atherosclerotic plaque; Detection and characterization of coronary artery plaque; Measurement of luminal stenoses; Analysis of coronary anatomy and pathology from CT Angiographic images; Workstation-based post-processing application; Automated vessel, plaque, and lumen segmentation (reviewable and editable by clinician); Review of heart and coronary vessels in Multiplanar Reformatting (MPR), curved MPR, and straightened MPR views; Measurement of vessel diameter and area | Cloud-based AI software for arrhythmia detection; Continuous ECG signal analysis; Detects various cardiac arrhythmias (e.g., atrial fibrillation, AV block, supraventricular tachycardia, ventricular tachycardia, pauses); Utilizes proprietary deep learning-based algorithm; Integrates with VitalPatch biosensor and Vista Solution platform; Displays detected arrhythmias for review by healthcare professionals via VistaCenter web application; Supports non-urgent clinical decision-making; Remote patient monitoring capabilities |
Videos
Demos, reviews, and walkthroughs featuring Autoplaque and VitalRhythm.